Table 3.
Protein | I/R | IPoC‐R | IPoC‐NR | IPC |
---|---|---|---|---|
Regulated by all three conditionings (n = 3) | ||||
Arrestin‐β2 | 1.97 ± 0.42 | 0.38 ± 0.36*** | 0.71 ± 0.50* | 0.79 ± 0.55* |
FOXn3 | 1.48 ± 0.18 | 0.68 ± 0.35** | 0.74 ± 0.38* | 0.55 ± 0.17*** |
Zbtb20 | 0.77 ± 0.14 | 0.35 ± 0.19* | 0.37 ± 0.16* | 0.45 ± 0.15* |
Selectively Regulated by IPoC‐R and IPoC‐NR but not by IPC (n = 3) | ||||
EFhd2 | 2.49 ± 0.66 | 0.33 ± 0.15** | 1.03 ± 0.59* | 1.03 ± 0.83 |
GRK2 | 1.39 ± 0.13 | 0.05 ± 0.02*** | 0.46 ± 0.31** | 0.95 ± 0.51 |
VEGF‐A | 0.69 ± 0.04 | 1.60 ± 0.23** | 1.65 ± 0.20** | 0.90 ± 0.50 |
Selectively Regulated by IPoC‐R and IPC (n = 7) | ||||
Coll‐3 | 4.26 ± 0.65 | 0.30 ± 0.13** | 2.06 ± 1.85 | 0.48 ± 0.37** |
Elastin | 3.02 ± 0.14 | 0.56 ± 0.34*** | 2.69 ± 1.24 | 0.54 ± 0.40** |
Psme3 | 1.31 ± 0.34 | 0.61 ± 0.27* | 0.74 ± 0.24 | 0.60 ± 0.10* |
Arginase‐1 | 1.18 ± 0.18 | 0.14 ± 0.05** | 1.02 ± 0.77 | 0.33 ± 0.19** |
CaSR | 0.89 ± 0.34 | 0.05 ± 0.01* | 0.32 ± 0.22 | 0.15 ± 0.09* |
Bcl‐2 | 0.82 ± 0.15 | 0.36 ± 0.09* | 0.75 ± 0.05 | 0.36 ± 0.09* |
Intermedin | 0.71 ± 0.30 | 0.03 ± 0.01* | 0.35 ± 0.31 | 0.09 ± 0.05* |
Selectively Regulated by IPoC‐R (n = 21) | ||||
Biglycan | 4.64 ± 0.85 | 0.89 ± 0.82*** | 2.90 ± 1.75 | 2.17 ± 2.42 |
Coll‐1 | 3.62 ± 0.97 | 0.79 ± 0.75** | 1.85 ± 1.20 | 1.76 ± 1.80 |
NOX2 | 2.43 ± 1.19 | 0.05 ± 0.02* | 0.52 ± 0.72 | 0.12 ± 0.10 |
Fibronectin | 2.13 ± 0.83 | 0.40 ± 0.42* | 1.24 ± 0.87 | 1.36 ± 1.52 |
JDP2 | 1.76 ± 0.47 | 0.44 ± 0.30** | 1.11 ± 0.65 | 1.52 ± 0.45 |
TGF‐β1 | 1.71 ± 0.15 | 0.54 ± 0.32** | 1.24 ± 0.67 | 1.36 ± 0.13 |
RAMP‐1 | 1.32 ± 0.39 | 0.17 ± 0.07* | 0.77 ± 0.51 | 0.29 ± 0.09 |
PTHrP | 1.24 ± 0.52 | 0.20 ± 0.06* | 0.76 ± 0.11 | 0.62 ± 0.35 |
RAMP‐3 | 1.17 ± 0.43 | 0.29 ± 0.09* | 0.74 ± 0.50 | 1.19 ± 0.73 |
iNOS | 1.09 ± 0.03 | 0.39 ± 0.14** | 0.92 ± 0.29 | 0.77 ± 0.34 |
Arginase‐2 | 1.05 ± 0.18 | 0.21 ± 0.10*** | 0.61 ± 0.35 | 0.80 ± 0.48 |
Arrestin‐β1 | 1.05 ± 0.35 | 0.29 ± 0.31* | 0.58 ± 0.29 | 0.49 ± 0.27 |
eNOS | 1.03 ± 0.08 | 0.50 ± 0.11*** | 0.73 ± 0.20 | 0.74 ± 0.48 |
RAMP‐2 | 0.98 ± 0.35 | 0.26 ± 0.05* | 0.65 ± 0.32 | 0.74 ± 0.50 |
GRK5 | 0.97 ± 0.15 | 0.28 ± 0.13*** | 0.59 ± 0.28 | 0.76 ± 0.38 |
MDM2 | 0.94 ± 0.17 | 0.48 ± 0.22* | 0.67 ± 0.36 | 1.25 ± 0.64 |
SDF‐1α | 0.90 ± 0.15 | 0.29 ± 0.21** | 0.50 ± 0.20 | 1.21 ± 1.07 |
Oxsr1 | 0.75 ± 0.18 | 0.36 ± 0.15* | 0.48 ± 0.28 | 0.41 ± 0.19 |
Ppargc1b | 0.71 ± 0.25 | 0.23 ± 0.15* | 0.25 ± 0.16 | 0.31 ± 0.09 |
SERCA2a | 0.70 ± 0.16 | 9.74 ± 4.74* | 5.02 ± 5.34 | 2.99 ± 2.47 |
AR‐B2 | 0.68 ± 0.04 | 0.26 ± 0.06*** | 0.68 ± 0.27 | 0.68 ± 0.04 |
PLB | 0.41 ± 0.04 | 1.74 ± 0.47 | 0.99 ± 0.75 | 1.66 ± 0.49 |
Socs7 | 0.19 ± 0.05 | 0.05 ± 0.03* | 0.12 ± 0.12 | 0.19 ± 0.18 |
Abbreviations: AR, adrenoceptor; bcl, B‐cell lymphoma; CaSR, calcium sensing receptor; Coll, collagen; EFhd, EF‐hand domain; FOX, forkhead box protein; GRK, G‐protein coupled receptor; JDP2, jun dimerization protein; MDM mouse double minute; NOS, nitric oxide synthase; NOX, NADPH oxidase; Oxsr, oxidative stress response; PLB, phospholamban; Ppargc, peroxisome proliferator‐activated receptor gamma co‐activator gamma; Psme, proteome activator subunit; PTHrP, parathyroid hormone‐related protein; RAMP, receptor activator modifying protein; SDF, stromal derived factor; SERCA, sarcoplamatic reticulum receptor calcium ATPase; Socs, Supressor of cytokine signalling; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; Zbtb, Zinc‐finger and BTB‐containing protein.
P < .05 vs I/R
P < .01 vs I/R
P < .001 vs I/R.